Reason for request
Re-assessment of the Actual Benefit and Improvement in Actual Benefit for the symptomatic treatment of idiopathic restless legs syndrome (RLS at the request of the Committee (pursuant to article R 163-21 of the French Social Security Code).
Clinical Benefit
| Moderate |
Moderate in patients with very severe idiopathic RLS. |
Clinical Added Value
| minor |
SIFROL provides a minor improvement in actual benefit (IAB IV) in the management of patients with very severe idiopathic restless legs syndrome. |
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
9x6WWJCkqNApUrCE
